» Articles » PMID: 1471654

Association of Intrauterine Fetal Growth Retardation and Learning Deficits at Age 9 to 11 Years

Overview
Publisher Elsevier
Date 1992 Dec 1
PMID 1471654
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined the association of fetal and newborn complications, socioeconomic status, and home environment with learning deficits as assessed between 9 and 11 years of age.

Study Design: A total of 218 high-risk newborns have been assessed at 1, 4, and 9 to 11 years of age. Fetal and newborn complications included 77 newborns with growth retardation. Socioeconomic variables included parental occupation and education. Outcome measures at 9 to 11 years included the Woodcock Reading Mastery Test and the Wide Range Achievement Test. Motor and cognitive development was assessed by a neurologic examination, the Bruininks-Oseretsky Test of Motor Proficiency, and the Wechsler Intelligence Scale for Children. Behavior was assessed with the Achenbach Child Behavior Check List and Connor's Teacher Rating Scale.

Results: Learning deficits were identified in 77 of the 218 children (35%). Children with learning deficits had lower full-scale IQ scores and behavioral problems of inattention and anxiety. Both fetal growth retardation and the father's occupation score were independently associated with these learning deficits.

Conclusion: Fetal growth retardation, socioeconomic status, and behavioral characteristics of inattention and anxiety are associated with less favourable academic achievement at 9 to 11 years of age.

Citing Articles

Human Cord Blood Endothelial Progenitor Cells and Pregnancy Complications (Preeclampsia, Gestational Diabetes Mellitus, and Fetal Growth Restriction).

Kwon J, Maeng Y Int J Mol Sci. 2024; 25(8).

PMID: 38674031 PMC: 11050478. DOI: 10.3390/ijms25084444.


International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood.

Hokken-Koelega A, van der Steen M, Boguszewski M, Cianfarani S, Dahlgren J, Horikawa R Endocr Rev. 2023; 44(3):539-565.

PMID: 36635911 PMC: 10166266. DOI: 10.1210/endrev/bnad002.


Impaired in vivo feto-placental development is associated with neonatal neurobehavioral outcomes.

Andescavage N, Bullen T, Liggett M, Barnett S, Kapse A, Kapse K Pediatr Res. 2022; 93(5):1276-1284.

PMID: 36335267 PMC: 10147575. DOI: 10.1038/s41390-022-02340-0.


Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn.

Chand K, Nano R, Wixey J, Patel J Stem Cells Transl Med. 2022; 11(4):372-382.

PMID: 35485440 PMC: 9052430. DOI: 10.1093/stcltm/szac005.


Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction.

Maki S, Kato I, Enomoto N, Takakura S, Nii M, Tanaka K J Clin Med. 2020; 9(5).

PMID: 32413997 PMC: 7291198. DOI: 10.3390/jcm9051448.